Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis

BACKGROUND: Mepolizumab (MPZ), an anti-interleukin-5 antibody, is effective for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA). However, its effectiveness has not been adequately evaluated in real-world clinical practice. In this study, we assessed the effectiveness and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Masanobu, Miyagawa, Ippei, Nakano, Kazuhisa, Iwata, Shigeru, Hanami, Kentaro, Fukuyo, Shunsuke, Kubo, Satoshi, Miyazaki, Yusuke, Kawabe, Akio, Yoshinari, Hiroko, Nakayamada, Shingo, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962235/
https://www.ncbi.nlm.nih.gov/pubmed/33726827
http://dx.doi.org/10.1186/s13075-021-02462-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962235/
https://www.ncbi.nlm.nih.gov/pubmed/33726827
http://dx.doi.org/10.1186/s13075-021-02462-6

Ejemplares similares